 |
|
Combination of Clinical Factors Predictive of Growth of Small Choroidal Melanocytic Tumors
Carol L. Shields, MD;
Jacqueline Cater, PhD;
Jerry A. Shields, MD;
Arun D. Singh, MD;
Maria Carmen M. Santos, MD;
Cynthia Carvalho, MD
Arch Ophthalmol. 2000;118:360-364.
Objective To better define the effect of individual risk factors and combinations thereof on the growth of small choroidal melanocytic tumors.
Design Retrospective analysis.
Setting Clinical practice of ocular oncology.
Patients The study included 1287 patients with small suspicious choroidal melanocytic tumors, measuring 3 mm or less in thickness, managed with observation.
Results On multivariate analysis, the clinical risk factors predictive of growth of small choroidal melanocytic tumors include tumor thickness greater than 2.0 mm, posterior tumor margin touching the disc, visual symptoms, orange pigment, and subretinal fluid. Tumor growth was detected in 4% of those patients with no risk factors. Growth was detected in approximately 36% of patients with 1 risk factor, 45% of patients with 2 risk factors, 50% of patients with 3 risk factors, 51% of patients with 4 risk factors, and 56% of patients with all 5 risk factors. The combination of risk factors offering the greatest risk for growth was tumor thickness greater than 2.0 mm, tumor margin touching disc, and subretinal fluid that was associated with tumor growth in 63% of the affected patients. The relative risk for growth was 1.9 for 1 factor, 3.8 for 2 factors, 7.4 for 3 factors, 14.1 for 4 factors, and 27.1 for all 5 risk factors combined.
Conclusions Five risk factors for growth of small choroidal melanocytic tumors have been identified. The combinations of various factors increase the risk for tumor growth from 4% if no factors are present to more than 50% if 3 or more risk factors are present. These factors may be important when counseling patients with small suspicious choroidal melanocytic tumors.
From the Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pa.
RELATED ARTICLE
Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2000;118(3):456.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma
Aaberg et al.
Br. J. Ophthalmol. 2008;92:741-746.
ABSTRACT
| FULL TEXT
Role of Cytogenetics in Management of Uveal Melanoma
Shields et al.
Arch Ophthalmol 2008;126:416-419.
FULL TEXT
Measurement of Human Choroidal Melanoma Xenograft Volume in Rats Using High-Frequency Ultrasound
Braun and Vistisen
IOVS 2008;49:16-22.
ABSTRACT
| FULL TEXT
Visual Acuity in 3422 Consecutive Eyes With Choroidal Nevus
Shields et al.
Arch Ophthalmol 2007;125:1501-1507.
ABSTRACT
| FULL TEXT
Fundus autofluorescence of choroidal nevus and melanoma
Lavinsky et al.
Br. J. Ophthalmol. 2007;91:1299-1302.
ABSTRACT
| FULL TEXT
Proton Beam Irradiation of Uveal Melanomas: The First 30 Years The Weisenfeld Lecture
Gragoudas
IOVS 2006;47:4666-4673.
FULL TEXT
Treating some small melanocytic choroidal lesions without waiting for growth.
Shields
Arch Ophthalmol 2006;124:1344-1346.
FULL TEXT
Long term ultrasonic follow up of choroidal naevi and their transformation to melanomas
Kaiserman et al.
Br. J. Ophthalmol. 2006;90:994-998.
ABSTRACT
| FULL TEXT
Histopathology of Documented Growth in Small Melanocytic Choroidal Tumors
Elner et al.
Arch Ophthalmol 2004;122:1876-1878.
FULL TEXT
Secondary retinal changes associated with choroidal naevi and melanomas documented by optical coherence tomography
Muscat et al.
Br. J. Ophthalmol. 2004;88:120-124.
ABSTRACT
| FULL TEXT
Mode of presentation and time to treatment of uveal melanoma in Finland
Eskelin and Kivela
Br. J. Ophthalmol. 2002;86:333-338.
ABSTRACT
| FULL TEXT
|
